verified SJR 1,197 · Q1 • database Scopus / SJR & Web of Science indexed

Netherlands · Elsevier B.V.

workspace_premium Q1 — Pharmacology lock Subscription

European Journal of Pharmacology

European Journal of Pharmacology is a journal indexed in SJR in Pharmacology with an H index of 210. It has an SJR impact factor of 1,197 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,197.

European Journal of Pharmacology focuses its scope in these topics and keywords: receptor, rat, inhibits, effect, receptors, effects, antagonist, model, blood, rats, ...

ISSN: 0014-2999

Publisher: Elsevier B.V.

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,197 Q1

H-index 210

Acceptance rate pie_chart

20% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,197

H-index

210

Docs (year)

718

Docs 3y

1949

Total refs

50681

Cites 3y

9768

Citable 3y

1949

Cites/Doc 2y

4.92

Ref/Doc

70.59

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Amrinone reduces ischaemia-reperfusion injury in rat heart

Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries

Changes in morphology of human skin fibroblasts induced by local anaesthetics: role of actomyosin contraction

Cardiovascular effects of centrally injected tetrahydroaminoacridine in conscious normotensive rats

Blockade of cardiac Na+ channels by a charged class I antiarrhythmic agent, bisaramil: possible interaction of the drug with a pre-open closed state

Behavioral and neurochemical effects of the preferential dopamine D3 receptor agonist cis-8-OH-PBZI

Autoradiographic visualisation of [3H]5-carboxamidotryptamine binding sites in the guinea pig and rat brain

Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models

Arachidonic acid and its metabolites are involved in the expression of morphine dependence in guinea-pig isolated ileum

Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits

Anti-arrhythmic effects of levcromakalim in the ischaemic rat heart: a dual mechanism of action?

Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT7 receptor

SHOW MORE ARTICLES

Anorectic effect of metformin in obese Zucker rats: lack of evidence for the involvement of neuropeptide Y

[3H]R-Terazosin binds selectively to a1-adrenoceptors over a2-adrenoceptors -comparison with racemic [3H]terazosin and [3H]prazosin

Altered non-adrenergic non-cholinergic neurotransmission in gastric fundus from streptozotocin-diabetic rats

Alkylating derivative of hexadecamethonium protects muscle synaptic acetylcholinesterase against inhibition

Affinities and intrinsic activities of dopamine receptor agonists for the hD21 and hD4.4 receptors

Adrenomedullin increases phosphatidylcholine secretion in rat type II pneumocytes

a1-Adrenoceptor subtypes mediating contractions of the rat mesenteric artery

A synthetic glycine-extended bombesin analogue interacts with the GRP/bombesin receptor

A performance-dependent adjustment of the retention interval in a delayed non-matching-to-position paradigm differentiates effects of amnestic drugs in rats

A nitric oxide synthase inhibitor reduces hyperphagia induced in rats by the 5-HT1A receptor agonist, 8-OH-DPAT, independently of hypothalamic serotonin metabolism

A Ca2+ channel blocker-like effect of dehydrocurdione on rodent intestinal and vascular smooth muscle

[Nphe1]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon

FAQs

European Journal of Pharmacology has an SJR of 1,197 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for European Journal of Pharmacology is 20%.

European Journal of Pharmacology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of European Journal of Pharmacology?

What is the APC / publication cost?

What is the acceptance rate?